Drug Type Gene therapy |
Synonyms |
Target |
Mechanism BACH1 inhibitors(BTB domain and CNC homolog 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization IMMvention Therapeutix, Inc.Startup |
Active Organization IMMvention Therapeutix, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anemia, Sickle Cell | Preclinical | US | IMMvention Therapeutix, Inc.Startup | 15 Jan 2024 |